ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q4Scopus Q4SCImago #28,856Hybrid

Revue Francaise D Allergologie

Acronym:reval
•
Abbreviation (ISO):REV FR ALLERGOL
•
Identifier (ISSN):1877-0320(Print)/1877-0312(Online)
•
Publisher:Elsevier Masson
Clarivate IF (2026)
0.2↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q4
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Revue Francaise D Allergologie

WoS Q4
00110.3120180.2620190.2520200.2920210.2520220.320230.520240.320250.22026
Annual Impact Factor Metric
Current (2026):0.2
Scopus SJR & RankScopus Q4
0.115
#28,856

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
21

21 papers with at least that number of citations each

WoS: SCIE / JCRQ4
Self-Citation Rate40%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
78articles/year
16.5% Gold OA•78.95% Original Research

Aims & Scope

La Revue Française d'Allergologie : un véritable forum pour faire connaître des travaux originaux et permettre la diffusion de l'information auprès de toutes les spécialités concernées par les pathologies allergiques. La Revue Française d'Allergologie (8 numéros par an) est au carrefour de nombreuses spécialités - dermatologie, pédiatrie, ORL, pneumologie, ophtalmologie, médecine interne - qui, toutes, ont à traiter des maladies allergiques. Les symptômes des allergies fondés sur des mécanismes communs sont le plus souvent associés et se succèdent chez un même patient. En forte progression depuis 20 ans, les maladies allergiques sont dans l'attente de perfectionnements et d'avancées thérapeutiques qui permettront aux nombreux patients qui en sont atteints de mieux vivre avec leurs allergies. La Revue Française d'Allergologie se veut donc un véritable forum de discussions et d'échanges entre tous les spécialistes confrontés aux pathologies

Topics Covered (Recognized by AI)
Medicine85.4%Gynecology46.2%Biology32.8%Philosophy26.6%Art25.5%Humanities25%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

ALLERGY

Q4
Rank40/40
IndexSCIE
JCISCIE2026

ALLERGY

Q4
Rank38/40
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF0.2
Articles / Year350
Total Citations1
2025
IF0.3
Articles / Year355
Total Citations28
2024
IF0.5
Articles / Year339
Total Citations64
2023
IF0.3
Articles / Year399
Total Citations97
2022
IF0.254
Articles / Year336
Total Citations179

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #28,856Scopus Q4SCImago Profile
Scopus Coverage:2009-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q4
0.115

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q4
Citations / Doc (2 years)
0.13

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$2,291 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations50
3-Year Documents352
Citable Documents298

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate62.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Immunology and AllergyQ4
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 40%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ALLERGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Revue Francaise D Allergologie (acronym: reval, abbr: REV FR ALLERGOL, ISSN: 1877-0320) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Masson in France. The periodical holds a Journal Impact Factor (JIF) of 0.20, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.115 (Q4), an H-index of 21.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 78 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,291 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Masson
Publication Language
French
Frequency
Bimonthly
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER MASSON, VIA PALEOCAPA 7, MILANO, ITALY, 20121

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 8b52f7fb-5c4a-4376-b48d-8a95739863e9
Database Updated: 2026-10-27